Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine

Northwestern University, Evanston, Illinois, United States
Journal of Biological Chemistry (Impact Factor: 4.57). 05/2007; 282(15):11590-601. DOI: 10.1074/jbc.M607483200
Source: PubMed


Oxidative stress is a major aspect of Alzheimer disease (AD) pathology. We have investigated the relationship between oxidative stress and neuronal binding of Abeta oligomers (also known as ADDLs). ADDLs are known to accumulate in brain tissue of AD patients and are considered centrally related to pathogenesis. Using hippocampal neuronal cultures, we found that ADDLs stimulated excessive formation of reactive oxygen species (ROS) through a mechanism requiring N-methyl-d-aspartate receptor (NMDA-R) activation. ADDL binding to neurons was reduced and ROS formation was completely blocked by an antibody to the extracellular domain of the NR1 subunit of NMDA-Rs. In harmony with a steric inhibition of ADDL binding by NR1 antibodies, ADDLs that were bound to detergent-extracted synaptosomal membranes co-immunoprecipitated with NMDA-R subunits. The NR1 antibody did not affect ROS formation induced by NMDA, showing that NMDA-Rs themselves remained functional. Memantine, an open channel NMDA-R antagonist prescribed as a memory-preserving drug for AD patients, completely protected against ADDL-induced ROS formation, as did other NMDA-R antagonists. Memantine and the anti-NR1 antibody also attenuated a rapid ADDL-induced increase in intraneuronal calcium, which was essential for stimulated ROS formation. These results show that ADDLs bind to or in close proximity to NMDA-Rs, triggering neuronal damage through NMDA-R-dependent calcium flux. This response provides a pathologically specific mechanism for the therapeutic action of memantine, indicates a role for ROS dysregulation in ADDL-induced cognitive impairment, and supports the unifying hypothesis that ADDLs play a central role in AD pathogenesis.

  • Source
    • "Interference with Aβ-HSPG binding via treatment with heparin or heparinase can mitigate these toxic effects of Aβ monomeric forms of Aβ (Aβ 1-40 and Aβ 1-42 ) on one vascular cell type (VSMC), our results may well have mechanistic implications on other forms of Aβ-induced CV dysfunction including that caused by vascular endothelial cell (VEC) dysfunction and that caused by higher order Aβ species. Support for the former comes from in vitro, ex vivo, and in vivo studies that implicate ROS in Aβinduced VEC dysfunction[13,17,57]and VEC-mediated vasomotor impairment;[13,17,575859support for the latter comes from in vitro and in vivo studies demonstrating that oligomeric Aβ (at least in neurons)[60]and fibrillar Aβ (in cerebral vessels and neurons)[18,6162636465cause even greater degrees of oxidative stress. Therefore, while elevated levels of soluble Aβ—and their attendant vascular consequences including altered CV reactivity[6]and impaired CBF[49,50]—are present in the early stages of AD when fibrillar Aβ in the form of neuritic plaques and CAA have yet to develop to a significant degree, the mechanisms elucidated in our study may very well exert their greatest impact on the later stages of AD when higher order Aβ species are much more abundant . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Substantial evidence suggests that amyloid-β (Aβ) species induce oxidative stress and cerebrovascular (CV) dysfunction in Alzheimer's disease (AD), potentially contributing to the progressive dementia of this disease. The upstream molecular pathways governing this process, however, are poorly understood. In this report, we examine the role of heparan sulfate proteoglycans (HSPG) in Aβ-induced vascular smooth muscle cell (VSMC) dysfunction in vitro. Results: Our results demonstrate that pharmacological depletion of HSPG (by enzymatic degradation with active, but not heat-inactivated, heparinase) in primary human cerebral and transformed rat VSMC mitigates Aβ1-40- and Aβ1-42-induced oxidative stress. This inhibitory effect is specific for HSPG depletion and does not occur with pharmacological depletion of other glycosaminoglycan (GAG) family members. We also found that Aβ1-40 (but not Aβ1-42) causes a hypercontractile phenotype in transformed rat cerebral VSMC that likely results from a HSPG-mediated augmentation in intracellular Ca(2+) activity, as both Aβ1-40-induced VSMC hypercontractility and increased Ca(2+) influx are inhibited by pharmacological HSPG depletion. Moreover, chelation of extracellular Ca(2+) with ethylene glycol tetraacetic acid (EGTA) does not prevent the production of Aβ1-40- or Aβ1-42-mediated reactive oxygen species (ROS), suggesting that Aβ-induced ROS and VSMC hypercontractility occur through different molecular pathways. Conclusions: Taken together, our data indicate that HSPG are critical mediators of Aβ-induced oxidative stress and Aβ1-40-induced VSMC dysfunction.
    Preview · Article · Dec 2016 · Molecular Neurodegeneration
    • "The trimer Ab oligomers can also contribute to the neuronal toxicity, albeit at a lower level compared to tetrameric Ab. The presence of trimeric and tetrameric but not dimeric species in the ADDLS preparations, which are highly toxic (Gong et al. 2003;De Felice et al. 2007) supports our model. As the trimer and tetramer oligomeric Ab species are highly toxic to neurons in culture, we need to determine the toxicity of purified Ab trimer and tetramer in vivo. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Amyloid beta (Aβ) peptide is the major constituent of the extracellular amyloid plaques deposited in the brains of Alzheimer's disease patients and is central to the pathogenic pathway causing this disease. The identity of the neurotoxic Aβ species remains elusive. We previously reported that Aβ toxicity correlates strongly with its neuronal cell binding leading us to hypothesise that neuronal cell death is caused by the binding of a specific oligomeric Aβ species. To identify the specific oligomeric Aβ species that is associated with cell death, we treated mouse cortical neuronal cultures with synthetic Aβ40 and Aβ42 peptides and identified that the cellular Aβ binding and neurotoxicity were time and concentration dependent. We found a significant correlation between the amount of trimer and tetramer species bound to neurons with increasing neurotoxicity. We prepared photo-induced cross-linking of unmodified peptides (PICUP) Aβ40 oligomers (up to tetramers) to confirm this oligomer-specific neurotoxic activity. Our results identify the Aβ tetramer, followed by the trimer, as the most toxic low order oligomers Aβ species. This article is protected by copyright. All rights reserved.
    No preview · Article · Nov 2015 · Journal of Neurochemistry
    • "s per the amyloid cascade hypothesis ) that may trigger synaptopathy , glial ( including microglial and astrocytic ) activation - related inflammatory response , neu - ronal ionic dyshomeostasis , oxidative damage , tau hyper - phosphorylation ( because of altered activities of relevant kinases and phosphatases ) , and eventual neuronal death ( De Felice et al . , 2007 ) . In neurofibrillary degeneration pathology , hyperphosphorylated tau protein accumulates in neurons as paired helical filaments in NFTs , induces abnormal cellular metabolism , and causes neuronal death . NFTs are associated with memory and cognitive dysfunc - tions ( Goedert , 1993 ; Wes et al . , 2014 ) . AD pathology starts years "
    [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of dementia and obstructive sleep apnea (OSA) increases with age. Late-onset Alzheimer's disease (AD) is an irreversible neurodegenerative disease of the elderly characterized by amyloid β (Aβ) plaques and neurofibrillary tangles. The disease involves widespread synaptic loss in the neocortex and the hippocampus. Rodent and clinical studies suggest that OSA impairs the structural integrity of several brain regions, including the medial temporal lobe. Indeed, hypoxia, hypertension, hypoperfusion, endothelial dysfunction, inflammation, and oxidative stress noted in OSA patients also occur in AD patients. This Review highlights pathological commonality, showing that OSA upregulates Aβ, tau hyperphosphorylation, and synaptic dysfunction. Indeed, OSA and hypertension trigger hypoperfusion and hypometabolism of brain regions, including cortex and hippocampus. Several studies show that hypertension-driven brain damage and pathogenic mechanisms lead to an Aβ increase. The pathophysiological mechanism by which OSA enhances hypertension may be linked to sympathoexcitation, oxidative stress, and endothelial dysfunction. Strong pathophysiological similarities that exist between OSA and AD are underscored here. For example, the hippocampus is negatively impacted in both OSA and AD. OSA promotes hippocampal atrophy, which is associated with memory impairment. Cognitive impairment, even in the absence of manifest dementia, is an important independent predictor of mortality. However, several pathophysiological mechanisms in OSA are reversible with appropriate therapy. OSA, therefore, is a modifiable risk factor of cognitive dysfunction, and treating OSA prior to mild cognitive impairment may be an effective prevention strategy to reduce risk for cognitive decline and AD in middle-aged persons and the elderly. © 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.
    No preview · Article · Aug 2015 · Journal of Neuroscience Research
Show more